The goal of the proposed research is to improve our understanding of memory and language dysfunctions in the early stages of Alzheimer's disease (AD) by assessing the nature of changes in the representations of knowledge that subserve perception, language, and memory. Such changes are manifested in speeded or biased responses to stimuli following exposure to those stimuli: The facilitated performance is termed priming. The proposed research derives from a new three-level model of priming that identifies separable learning processes supporting distinct components of vision and language. The model is motivated by memory-systems analyses that relate specific kinds of learning to separable neural systems on the basis of spared and impaired learning capacities in patients with global amnesia or AD. The model postulates three dissociable levels of priming: (1) perceptual-structural priming, reflecting visuoperceptual learning processes intact in amnesia and in AD; (2) lexical-semantic priming, reflecting semantic-retrieval learning processes intact in amnesia and impaired in AD; and (3) event-fact priming, reflecting contextual learning processes impaired in amnesia and in AD. The model generates four hypotheses which we propose to test over five years in seven multi-experiment studies with 100 mildly-to- moderately demented AD patients and 100 normal control subjects. The newly obtained empirical evidence will guide us in restructuring our integrative model of priming functions in normal subjects and priming dysfunctions in AD patients. In turn, the revised model will improve our understanding of the functional organization of the neural systems that subserve normal perception, language, and memory, and may reveal how damage to those systems leads to dementia in AD. The elaboration of a theoretical framework that is well supported by empirical evidence should be useful in the development of valid and sensitive behavioral testing instruments for assessing the efficacy of putative cognition- enhancing drugs in AD and other age-related neurological diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005134-07
Application #
3809172
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Dujardin, Simon; Bégard, Séverine; Caillierez, Raphaëlle et al. (2018) Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathol Commun 6:132
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
DeVos, Sarah L; Corjuc, Bianca T; Commins, Caitlin et al. (2018) Tau reduction in the presence of amyloid-? prevents tau pathology and neuronal death in vivo. Brain 141:2194-2212
Lee, Christopher M; Jacobs, Heidi I L; Marquié, Marta et al. (2018) 18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal. J Alzheimers Dis 62:1691-1702
Eftekharzadeh, Bahareh; Daigle, J Gavin; Kapinos, Larisa E et al. (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron 99:925-940.e7
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Emerson, Sarah C; Waikar, Sushrut S; Fuentes, Claudio et al. (2018) Biomarker validation with an imperfect reference: Issues and bounds. Stat Methods Med Res 27:2933-2945
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739

Showing the most recent 10 out of 966 publications